Mpox mRNA-1769 vaccine inhibits orthopoxvirus replication at intranasal, intrarectal, and cutaneous sites of inoculation.

MLA

Cotter, Catherine A., et al. “Mpox MRNA-1769 Vaccine Inhibits Orthopoxvirus Replication at Intranasal, Intrarectal, and Cutaneous Sites of Inoculation.” NPJ Vaccines, vol. 9, no. 1, Dec. 2024, pp. 1–12. EBSCOhost, https://doi.org/10.1038/s41541-024-01052-2.

APA

Cotter, C. A., Ignacio, M. A., Americo, J. L., Earl, P. L., Mucker, E. M., Frey, T. R., Carfi, A., Hooper, J. W., Freyn, A. W., & Moss, B. (2024). Mpox mRNA-1769 vaccine inhibits orthopoxvirus replication at intranasal, intrarectal, and cutaneous sites of inoculation. NPJ Vaccines, 9(1), 1–12. https://doi.org/10.1038/s41541-024-01052-2

Chicago

Cotter, Catherine A., Maxinne A. Ignacio, Jeffrey L. Americo, Patricia L. Earl, Eric M. Mucker, Tiffany R. Frey, Andrea Carfi, Jay W. Hooper, Alec W. Freyn, and Bernard Moss. 2024. “Mpox MRNA-1769 Vaccine Inhibits Orthopoxvirus Replication at Intranasal, Intrarectal, and Cutaneous Sites of Inoculation.” NPJ Vaccines 9 (1): 1–12. doi:10.1038/s41541-024-01052-2.